Podcast: The British start-up taking psychedelic therapy mainstream
In our first podcast interview of 2023, BioPharma Reporter spoke with Dr Sarah Bateup, therapy...
28:03
What kind of consistency can industry expect from the FDA post pandemic?
How the US Food and Drug Administration (FDA) exercises flexibility has been an important and...
14:34
What kind of consistency can industry expect from the FDA post pandemic?
How the US Food and Drug Administration (FDA) exercises flexibility has been an important and...
14:34
Chicago emerging as a life science and biopharma hub
Many turn to Boston and North Carolina’s Research Triangle to set up life science companies, but...
14:26
Chicago emerging as a life science and biopharma hub
Many turn to Boston and North Carolina’s Research Triangle to set up life science companies, but...
14:26
Will Biden backed bills boost biosimilars uptake in the US?
Today we are launching a new series called The BioPharma Pod. Kicking off these broadcasts is the...
08:18
Bioproduction bottlenecks increasing due to staff shortages, says report
A shortage in expertise is causing bottlenecks in the biomanufacturing space with around half of...
03:31
Bioproduction bottlenecks increasing due to staff shortages, says report
A shortage in expertise is causing bottlenecks in the biomanufacturing space with around half of...
03:31
'The sexiness of the ADC world' - CMOs talk antibody-drug hybrids at CPhI
Piramal’s COO Vijay Shah described antibody-drug conjugates (ADCs) as “a concept whose time has...
05:12
'The sexiness of the ADC world' - CMOs talk antibody-drug hybrids at CPhI
Piramal’s COO Vijay Shah described antibody-drug conjugates (ADCs) as “a concept whose time has...
05:12
Better single-use cross flow techs still needed says GE Healthcare
The biopharmaceutical manufacturing sector needs better cross flow filtration technologies...
02:35
Better single-use cross flow techs still needed says GE Healthcare
The biopharmaceutical manufacturing sector needs better cross flow filtration technologies...
02:35
Immunocore CEO: 3rd Big Pharma Eying Unique Cancer Targeting Tech
Immunocore is looking for more licensees for its cancer targeting technology following recent...
04:40
Immunocore CEO: 3rd Big Pharma Eying Unique Cancer Targeting Tech
Immunocore is looking for more licensees for its cancer targeting technology following recent...
04:40
Customers to Save up to 65% as ASI and Chromatan Pen Single-Use Deal
ASI has teamed up with Chromatan in order to deliver single-use and column-free capture...
04:38
Customers to Save up to 65% as ASI and Chromatan Pen Single-Use Deal
ASI has teamed up with Chromatan in order to deliver single-use and column-free capture...
04:38
Customers to Save up to 65% as ASI and Chromatan Pen Single-Use Deal
ASI has teamed up with Chromatan in order to deliver single-use and column-free capture...
04:38
ATMI: Single Use Bioreactors on the Up, but US Tails Europe
New innovations in single-use bioprocessing systems are being picked up quicker in Europe than in...
04:13
ATMI: Single Use Bioreactors on the Up, but US Tails Europe
New innovations in single-use bioprocessing systems are being picked up quicker in Europe than in...
04:13
Lo último de Negocios y sectores
![#27: Embracing Imperfect Sales & Figuring It Out as You Go With Nimisha Kantharia [Soulful Selling Stories]](https://img-static.ivoox.com/index.php?w=77&h=77&url=https://static-2.ivoox.com/canales/3/0/9/6/9171553736903_XXL.jpg)
Adf195
Episodio
Premium
Plus